This inventor holds 3 USPTO granted patents. Top assignee: Amgen Inc.. Active years: 2005-2009.
Location History:
- San Diego, CA (US) (2005 - 2007)
- Great Neck, NY (US) (2009)
Company Filing History:
Years Active: 2005-2009
Title: John F Kincaid: Innovator in Calcium Receptor Modulation
Introduction
John F Kincaid is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of calcium receptor modulating agents. With a total of 3 patents to his name, Kincaid's work has the potential to impact the treatment of bone disorders.
Latest Patents
Kincaid's latest patents focus on calcium receptor modulating agents. These compounds are designed to reduce or inhibit parathyroid hormone (PTH) secretion. The inventions include methods for treating or preventing diseases associated with bone disorders, such as osteoporosis, and conditions related to excessive PTH secretion, like hyperparathyroidism. The patents also cover processes for synthesizing these compounds and the intermediates used in their production.
Career Highlights
Kincaid is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to further his research and development efforts in the pharmaceutical industry. His innovative approach to calcium receptor modulation has positioned him as a key figure in this area of research.
Collaborations
Kincaid has collaborated with several notable colleagues, including Michael G Kelly and Shimin Xu. These collaborations have enhanced his research and contributed to the advancement of their shared goals in the field of pharmaceuticals.
Conclusion
John F Kincaid's contributions to the development of calcium receptor modulating agents highlight his role as an influential inventor in the pharmaceutical industry. His work has the potential to significantly improve treatments for bone disorders and related conditions.